Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis

Registry ID

EUCTR2006-001796-37

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

Start date

2006-06-07

Last update

2026-08-16

Conditions

• postmenopausal osteoporosis

Summary

to study the effect of in vivo alendronate 70 mg once/weekly in vitro on spontaneous osteoclastogenesis in postmenopausal osteoporosis

Locations

• , , Italy

View on source registry